Abingworth
Diya joined Abingworth in June 2021 from L.E.K. Consulting. She works with the transatlantic investment team, in particular the Clinical Co-Development team, to evaluate new investment opportunities and support existing investments.
As a Consultant with L.E.K. Consulting’s Life Sciences practice, Diya advised pharmaceutical, biotech, and early and late-stage buyside clients on a range of projects including corporate strategy, and clinical and commercial opportunity assessments.
Diya holds a Ph.D. in Clinical Neuropharmacology from Imperial College London and a degree in Pharmacology from University College London.
This person is not in any offices
Abingworth
1 followers
Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs to develop their ideas into products that have a dramatic impact on health. With over $1 billion under management, Abingworth invests at all stages of development, from start-ups to publicly traded companies, and across all life sciences sectors. Supporting its portfolio companies with a team of 25 at offices in London, Menlo Park, and Boston, Abingworth has invested in 151 life science companies, completed 65 IPOs and 42 mergers and acquisitions.